BeyondSpring Inc (BYSI)

NASDAQ
3.30
-0.02(-0.60%)
  • Volume:
    217,743
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    3.18 - 3.44

BYSI Overview

Prev. Close
3.32
Day's Range
3.18-3.44
Revenue
1.2M
Open
3.4
52 wk Range
2.91-33
EPS
-1.92
Volume
217,743
Market Cap
128.78M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,863,074
P/E Ratio
-
Beta
1
1-Year Change
-75.32%
Shares Outstanding
39,142,253
Next Earnings Date
Apr 29, 2022
What is your sentiment on BeyondSpring Inc?
or
Vote to see community's results!

  • BeyondSpring Cuts On-Third Of Its Workforce
    • ByBenzinga-

    BeyondSpring Inc (NASDAQ: BYSI) plans to reduce its U.S. workforce by 35%, including reassignment of certain personnel to subsidiaries, which is expected to result in cost savings...

  • BeyondSpring EPS misses by $0.10
    • BySeeking Alpha-

    BeyondSpring (BYSI): Q3 GAAP EPS of -$0.48 misses by $0.10.Press ReleaseAs of September 30, 2021, the company had cash, cash equivalents, and short-term investments of...

BeyondSpring Inc Company Profile

Employees
91

BeyondSpring Inc. is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin product is a marine-derived small-molecule selective immunomodulating microtubule-binding agent (SIMBA) with a range of immune activities. Its Plinabulin has the immune defense protein, GEF-H1, which leads to two effects: a durable anti-cancer benefits due to the maturation of dendritic cells resulting in activation of tumor antigen-specific T-cells to target cancer cells and early-onset action in chemotherapy-induced neutropenia (CIN) prevention after chemotherapy by boosting the number of hematopoietic stem/progenitor cells (HSPCs).

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong SellSellStrong SellStrong Sell
SummaryStrong BuyStrong SellStrong SellStrong SellStrong Sell
  • $70s incoming
    2
    • I was right. Yay me.
      0
      • here we go. ride the wave, in with 1000 shares at 9.56
        0
    • Another pump n dump. Everyones chasing the next med stock in hopes of ending the covidnoia It's not going to happen. Covid is a tool the corrupt governments have now to control the people and they'll never give it up. It's how they'll rig the 2022 mid term as well.
      8
      • Uzbekistan??
        0
      • Nison KayUganda??
        0
      • Uruguay??
        0
    • what's going on  is it stuck on 24.59?
      1
      • Halted due to volatility. Resumed trading though and climbing. =)
        0
    • HC Wainwright & Co upgrades BYSI on trial results news and sets PT of $100
      0
      • "shorty get down, good lord" music quotes that make a lot of sense rn
        0
        • :) who buy from here lol stupid pre market
          0
          • Real PT of $25EOY and PT of $200 if an acquisition comes in. It's at the bottom right now at 10.60. BUY
            1
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.